Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd.

Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd. (hereinafter referred to as "No.1 Biochemical") originated in 1937 and was formed in 1994 through the merger of Shanghai Pharmaceutical Factory and Shanghai Biochemical Pharmaceutical Factory. The company offers a wide range of products, focusing on the production of injections and active pharmaceutical ingredients (APIs). Its product portfolio covers biochemical pharmaceuticals, Chinese herbal medicines, and chemical pharmaceuticals, including sterile water injections and powder injections. It possesses core production technologies such as biological extraction, purification, Chinese herbal extraction, and integrated API preparation, and is a designated production base for national essential drugs.
No.1 Biochemical is committed to building a "premium intelligent manufacturing base for high-end injections in China," leading the industry in biopharmaceutical R&D, high-end intelligent manufacturing, digital transformation of the pharmaceutical industry, and green factory construction. It has been honored for many years with titles such as Shanghai Civilized Unit and Shanghai High-Tech Enterprise, and has received numerous awards including the First Prize of Shanghai Science and Technology Progress Award, the Gold Award of Shanghai Excellent Invention Selection, and recognition as one of Shanghai's Top Ten High-Tech Transformations. The company continues to build its digital factory, becoming a Shanghai Intelligent Factory (high-end injections) in 2022, and has been recognized by the Ministry of Industry and Information Technology as an excellent scenario for intelligent manufacturing, a pioneer in digital transformation of Shanghai's biopharmaceutical industry, and its "Digital Requirements for Biopharmaceutical Quality Control Laboratories" has been awarded the Shanghai Standard mark. Additionally, the company undertakes one of Shanghai's major municipal special projects: the development of a key prototype for continuous manufacturing of cardiovascular drugs, converting large equipment into small chips to explore cutting-edge cross-disciplinary research. The company prioritizes energy conservation, environmental protection, and safety, and has been named one of Shanghai's first demonstration units for green manufacturing systems, as well as a green factory.
No.1 Biochemical adheres to high-quality development led by Party building, upholding the founding aspiration of "industrial patriotism, saving lives, and serving the people with medicine." It integrates the Party's original mission with the company's own purpose, revitalizing the "Four Goods culture" of "the enterprise being good to employees, employees being good to products, products being good to patients, and patients making the enterprise good." The company promotes the entrepreneurial spirit of "every injection conveys deep affection, trustworthy for life," striving to build a safety barrier that safeguards people's lives and well-being.